Intermolecular (IMI) Tops Q4 EPS by 3c

Intermolecular (NASDAQ: IMI) reported Q4 EPS of ($0.05), $0.03 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $10.5 million versus the consensus estimate of $10.2 million.

For earnings history and earnings-related data on Intermolecular (IMI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c